Experimental Colitis in Animal Models

References

• Strober W. Animal models of inflammatory bowel disease— an overview. Dig Dis Sci 1985; 30: 3–10, Suppl
   PubMed Web of Science ®Google Scholar
• Chalifoux LV, Bronson RT. Colonic adenocarcinoma associated with chronic colitis in cotton-top marmosets, Saguinus oedipus. Gastroenterology 1981; 80: 942–6
   PubMed Web of Science ®Google Scholar
• Madara JL, Podolsky DK, King NW, Sehgal PK, Moore R, Winter HS. Characterization of spontaneous colitis in cotton-top tamarin (Saguinus oedipus) and its response to sulfasalazine. Gastroenterology 1985; 88: 13–9
   PubMed Web of Science ®Google Scholar
• Lushbach C, Humason G, Clapp N. Histology of colitis: Saguinus oedipus and other marmosets. Dig Dis Sci 1985; 30: 45–51, Suppl
   PubMed Web of Science ®Google Scholar
• Podolsky DK, Madara JL, King NW, Sehgal PK, Moore R, Winter HS. Colonic mucin composition in primates: selective alterations associated with spontaneous colitis in the cotton-top tamarin. Gastroenterology 1988; 88: 20–5
   Google Scholar
• Clapp NK, Walsh RE, Fretland DJ, Henke MA, Gaginella TS. Inflammatory mediators in the plasma of cotton-top tamarins with acute and chronic colitis [abstract]. Gastroenterology 1990; 98: A442
   Google Scholar
• Panzini B, King N, Sehga P, Podolsky DK. Role of leukotrienes in the colitis of the cotton-top tamarin: effect of a 5 lipoxygenase inhibitor [abstract]. Gastroenterology 1990; 98: A468
   Google Scholar
• Takahashi F, Das KM. Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis. J Clin Invest 1985; 76: 311–8
   PubMed Web of Science ®Google Scholar
• Das KM, Squillante L, Henke M, Clapp N. The presence of circulating antibodies in cotton top tamarins (CTT) with spontaneous colitis against an epitope(s) on MR 40,000 protein shared by human and CTT colon epithelial cells [abstract]. Gastroenterology 1990; 98: A444
   PubMed Web of Science ®Google Scholar
• Adler R, Hendrickx A, Rush J, Fondacaro JD. Chronic colitis of Juvenile Rhesus Macaques: mucosal tissue levels of interleukin-1 (IL-1) and leukotriene B4 (LTB-4) [abstract]. Gastroenterology 1990; 98: A436
   Google Scholar
• MacPherson BR, Pfeiffer CJ. Experimental production of diffuse colitis in rats. Digestion 1978; 17: 135–50
   PubMed Web of Science ®Google Scholar
• Fretland DJ, Widomski DL, Tsai BS, et al. Effect of leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit. J Pharmacol Exp Ther 1990; 255: 572–6
   PubMed Web of Science ®Google Scholar
• Sharon P, Stenson WF. Metabolism of arachidonic acid in acetic acid colitis in rats: similarity to human inflammatory bowel disease. Gastroenterology 1985; 88: 55–63
   PubMed Web of Science ®Google Scholar
• Fretland DJ, Levin S, Tsai BS, et al. The effect of leukotriene-B4 receptor antagonist, SC-41730, on acetic acid-induced colonic inflammation. Agents Actions 1989; 27: 225–7
   Google Scholar
• Goetzl EJ, Pickett WC. The human PMN leukocyte chemo-tactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). J Immunol 1980; 125: 1789–91
   PubMed Web of Science ®Google Scholar
• Zeitlin IJ, Norris AA. Animal models of colitis. Mechanisms of gastrointestinal inflammation, VS Chadwick. Smith Kline and French, Welwyn Garden CityUK 1984; 70–3
   Google Scholar
• Reber S, Su K, Leung FW., Guth PH. Exogenous prostaglandin and indomethacin protect against the development of acetic acid colitis in the rats [abstract]. Clin Res 1989; 37: 113A
   Google Scholar
• Fedorak RN, Espey LR, MacArthur C, Jewell LD. Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. Gastroenterology 1990; 98: 615–25
   PubMed Web of Science ®Google Scholar
• Waisman Y, Zahavi I, Marcus H, Ligumsky M, Rosenbach Y, Dinari G. Sucralfate is protective against indomethacin-induced intestinal ulceration in the rat. Digestion 1988; 41: 78–82
   PubMed Web of Science ®Google Scholar
• Conzentino P, Will PC, Lin A, Gaginella TS. Effect of 5-lipoxvgenase inhibitors on acetic acid colitis in the rat. Pharmacologist 1986; 28: 163
   Google Scholar
• Wallace JL, Whitle BJR, Boughton-Smith NK. Prostaglandin protection of rat colonic mucosa from damage induced by ethanol. Dig Dis Sci 1985; 30: 866–76
   PubMed Web of Science ®Google Scholar
• Fretland DJ, Widomski DL, Levin S., Gaginella TS. Colonic inflammation in the rabbit induced by phorbol-12-myristate-13-acetate. Inflammation 1990; 14: 143–50
   PubMed Web of Science ®Google Scholar
• Ashendel CL. The phorbol ester receptor: a phospholipid-regulated protein kinase. Biochim Biophys 1985; 822: 219–42
   PubMed Web of Science ®Google Scholar
• McLntyrc TM, Reinhold SL, Prescott SM, Zimmerman GA. Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils. J Biol Chem 1987; 262: 15370–6
   PubMed Web of Science ®Google Scholar
• McColl SR, Hurst NP, Betts WH, Cleland LG. Modulation of human neutrophil LTA hydrolase activity by phorbol myristate acetate. Biochem Biophys Res Commun 1987; 147: 622–46
   PubMed Web of Science ®Google Scholar
• Leurs R., Go JNL, Bast A, Timmerman H. Involvement of protein kinase C in the histamine Hl-receptor mediated contraction of guinea pig lung parenchymal strips. Agents Actions 1989; 27: 180–3
   PubMedGoogle Scholar
• Danilov YN, Juliano RL. Phorbol ester modulation of integrin-mediated cell adhesion: a postreceptor event. J Cell Biol 1989; 108: 1925–33
   PubMed Web of Science ®Google Scholar
• Gerard C, McPhail LC, Marfat A, Stimler-Gerard NP, Bass DA, McCall CE. Role of protein kinases in stimulation of human polymorphonuclear leukocyte oxidative metabolism by various agonists. J Clin Invest 1986; 77: 61–5
   PubMed Web of Science ®Google Scholar
• Aparico-Pages MN, Werspaget HW, Pena AS, et al. Natural, lectin and phorbolester-induced cellular cytotoxicity in Crohn's disease and ulcerative colitis. J Clin Lab Immunol 1988; 27: 109–13
   PubMedGoogle Scholar
• Marcus R, Watt J. Seaweeds and ulcerative colitis in laboratory animals. Lancet 1969; 2: 489–90
   PubMed Web of Science ®Google Scholar
• Watt J, Marcus R. Progress report, experimental ulcerative disease of the colon in animals. Gut 1973; 14: 506–10
   PubMed Web of Science ®Google Scholar
• Benitz KF, Goldberg L, Coulston F. Intestinal effects of car-rageenan in the rhesus monkeys. Food Cosmet Toxicol 1973; 11: 565–75
   PubMedGoogle Scholar
• Abraham R, Fabian RJ, Goldberg L, Coulston F. Role of lysosomes in carrageenan-induced cecal ulceration. Gastroenterology 1974; 67: 1169–81
   PubMed Web of Science ®Google Scholar
• Marcus SN, Kline TJ, Pothoulakis H, et al. Role of inflammatory mediators in the pre-ulcerative phase of carrageenan-induced ulcerative disease of the colon (CIUDC) [abstract]. Gastroenterology 1990; 98: A461
   Google Scholar
• Bores DL. Granulomatous inflammations. Prog Allergy 1978; 24: 183–267
   PubMedGoogle Scholar
• Thomson AW, Fowler EF. Carrageenan: a review of its effects on the immune system. Agents Actions 1981; 11: 265–73
   PubMedGoogle Scholar
• Onderdonk AB, Hermos JA, Dzink JL, Bartlett JG. Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology 1978; 74: 521–6
   PubMed Web of Science ®Google Scholar
• Onderdonk AB, Bartlett JG. The role of bacteria in experimental ulcerative colitis. Am J Clin Nutr 1979; 32: 258–65
   PubMed Web of Science ®Google Scholar
• Onderdonk AB, Cisneros RL, Bronson RT. Enhancement of experimental ulcerative colitis by immunization with Bac-teroides vulgatus. Infect Immun 1983; 42: 783–8
   PubMed Web of Science ®Google Scholar
• Watt J, Marcus R. Ulceration of the colon in rabbits fed sulfated amylopectin. J Pharm Pharmacol 1972; 24: 68–9
   PubMed Web of Science ®Google Scholar
• Ohkusa T. Production of experimental ulcerative colitis in hamsters by dextran sulfate sodium and change in intestinal microflora. Jpn J Gastroenterol 1985; 82: 1327–36
   PubMedGoogle Scholar
• Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694–702
   PubMed Web of Science ®Google Scholar
• Marcus R, Watt J. Ulcerative disease of the colon in laboratory animals induced by pepsin inhibitors. Gastroenterology 1974; 67: 473–83
   PubMed Web of Science ®Google Scholar
• Ohno S, Notsuki I, Kawai T. Histochemical studies on acid mucopolysaccharide. I. Histochemical detection of hyalulonic acid. Med Biol 1951; 19: 326–8
   Google Scholar
• Ohkusa T, Okayasu I, Ozaki 1, Yamada M, Nakaya R. Changes in bacterial phagocytosis of macrophage in experimental ulcerative colitis [abstract]. Gastroenterology 1990; 98: A467
   Google Scholar
• Sartor RB, Anderle SK, Rifai N, Goo DAT, Cromartie WJ, Schwab JH. Protracted anemia associated with chronic, relapsing systemic inflammation induced by arthropathic peptido-glycan-polysaccharide polymers in rats. Infect Immun 1989; 57: 1177–85
   PubMed Web of Science ®Google Scholar
• Ling K-Y, Bhalla D, Hollander D. Mechanisms of carrageenan injury of IEC18 small intestinal epithelial cell monolayers. Gastroenterology 1988; 95: 1487–95
   PubMed Web of Science ®Google Scholar
• Schiffmann E, Showell HV, Corcoran BA, Ward PA, Smith E, Becker EL. The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J Immunol 1975; 114: 1831–7
   PubMed Web of Science ®Google Scholar
• Schiffmann E, Corcoran BA, Wahl SM. N-Formylmethionyl peptides as chemoattractants for leukocytes. Proc Natl Acad Sci USA 1975; 72: 1059–62
   PubMed Web of Science ®Google Scholar
• Showell HJ, Freer RJ, Zigmon SH, et al. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils. J Exp Med 1976; 143: 1154–69
   PubMed Web of Science ®Google Scholar
• Ho PPK, Young AL, Southard GL. Methyl ester of N-formyl-methionyl-leucyl-phenylalanine. Arthritis Rheum 1978; 21: 133–6
   PubMed Web of Science ®Google Scholar
• Chadwick VS, Mellor DM, Myers DB, et al. Production of peptides inducing chemotacsis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo. Scand J Gastroenterol 1988; 23: 121–8
   PubMed Web of Science ®Google Scholar
• Marasco WA, Phan SH, Krutzch H, et al. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chcmotactic factor produced by Escherichia coli. J Biol Chem 1984; 259: 5430–9
   PubMed Web of Science ®Google Scholar
• Williams LT, Synderman R, Pike MC, Lefkowitz RJ. Specific receptor site for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 1977; 74: 1204–8
   PubMed Web of Science ®Google Scholar
• Painter GR, Sklar LA, Jesatis AJ, Schmitt M, Cochrane CG. Activation of neutrophils by N-formyl chemotactic peptides. Fed Proc 1984; 43: 2737–42
   PubMedGoogle Scholar
• Bradford PG, Rubin RP. Pertussis toxin inhibits chemotactic factor-induced phospholipase C stimulation and lysosomal enzyme secretion in rabbit neutrophils. FEBS Lett 1985; 18: 317–20
   Google Scholar
• Naccache PH, Molski TFP, Bargeat P, White JR, Sha'afi RI. Phorbol esters inhibit the f-Mct-Leu-Phe and leukotriene B4 stimulated calcium mobilization and enzyme secretion in rabbit neutrophils. J Biol Chem 1985; 260: 2125–31
   PubMed Web of Science ®Google Scholar
• Turner SR, Campbell JA, Lynn WS. Polymorphonuclear leukocyte chemotaxis toward oxidized lipid components of cell membranes. J Exp Med 1975; 141: 1437–41
   PubMed Web of Science ®Google Scholar
• Yuli I, Tomonaga A, Snyderman R. Chemoattractant receptor functions in human polymorphonuclear leukocytes are divergently altered by membrane fluidizers. Proc Natl Acad Sci USA 1982; 79: 5906–10
   PubMed Web of Science ®Google Scholar
• Snyderman R. Regulatory mechanisms of a chemoattractant receptor on leukocytes. Fed Proc 1984; 43: 2743–8
   PubMedGoogle Scholar
• Korchak HM, Vienne K, Rutherford LE, Weissman G. Neutrophil stimulation: receptor, membrane, and metabolic events. Fed Proc 1984; 43: 2749–54
   PubMedGoogle Scholar
• Palblad J, Gyllenhammer H, Lindgren JA, Malmsten CI. Effects of leukotrienes and f-Met-Leu-Phe on oxidative metabolism of neutrophils and eosinophils. L Immunol 1984; 132: 3041–5
   Web of Science ®Google Scholar
• Beckman JK, Gay JC, Brash AR, Lukens JN, Oates JA. Stimulation by lipoxygenase products of superoxide anion production in FMLP-treated neutrophils. Lipids 1985; 20: 318–21
   PubMed Web of Science ®Google Scholar
• Beckman JK, Gay JC, Brash AR, Lukens JN, Oates JA. Different effects of lipoxygenase products on FMLP and LTB4 evoked neutrophil aggregation. Lipids 1985; 20: 357–60
   PubMed Web of Science ®Google Scholar
• Goetzl E., I, Austen KF. Purification and synthesis of eosinophilic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis. Proc Natl Acad Sci USA 1975; 72: 4123–7
   PubMed Web of Science ®Google Scholar
• Bokoch GM, Reed PW. Stimulation of arachidonic acid metabolism in the polymorphonuclear leukocyte by an N-formylated peptide. J Biol Chem 1980; 255: 10223–6
   PubMed Web of Science ®Google Scholar
• Salari H, Braquet P, Naccache P., Borglat P. Characterization of effect of N-formyl-methionyl-leucyl-phenylalanine on leukotriene synthesis in human polymorphonuclear leukocytes. Inflammation 1985; 9: 127–38
   PubMed Web of Science ®Google Scholar
• Jubiz W, Radmark O, Malmsten C, et al. A novel leukotriene produced by stimulation of leukocytes with formyl-methionyl-ieucyi-phenylalaninc. J Biol Chem 1982; 257: 6106–10
   PubMed Web of Science ®Google Scholar
• Goetzl E. I, Bbindley LL, Goldman DW. Enhancement of human neutrophil adherence by synthetic leukotriene constituents of the slow-reacting substance of anaphylaxis. Immunology 1983; 50: 35–41
   PubMed Web of Science ®Google Scholar
• Goldman DW, Goetzl EJ. Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chcmotactic response. J Exp Med 1984; 159: 1027–41
   PubMed Web of Science ®Google Scholar
• Kay AB, Austen KF. Ig-E mediated release of an eosinophil leukocyte chemotactic factor from human lung. J Immunol 1971; 107: 899–902
   PubMed Web of Science ®Google Scholar
• Barrett TA, Musch MW, Chang EB. Chemotactic peptide effects on intestinal electrolyte transport. Am J Physiol 1990; 259: G947–54
   Google Scholar
• LeDuc LE, Nast CC. Chemotactic peptide-induced acute colitis in rabbits. Gastroenterology 1990; 98: 929–35
   PubMed Web of Science ®Google Scholar
• Magnusson KE, Dahlgren C, Sjolander A. Effect of N-for-mylated-methionyl-leucyl-phenylalanine on gut permeability. Inflammation 1985; 9: 365–73
   PubMed Web of Science ®Google Scholar
• Teir H, Rytomma T, Cederberg A, Kiviniemi K. Studies on the elimination of granulocytes in the intestinal tract in rat. Acta Pathol Microbiol Scand 1963; 59: 311–24
   PubMedGoogle Scholar
• Nash S, Stafford J, Madara JL. Effects of polymorphonuclear lymphocyte transmigration on the barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1987; 80: 1104–13
   PubMed Web of Science ®Google Scholar
• von Ritter C, Sckizuka E, Grisham MB, Granger DN. The chemotactic peptide N-formyl methionyl-leucyl-phenylalanine increases mucosal permeability in the distal ileum of the rat. Gastroenterology 1988; 95: 651–6
   PubMed Web of Science ®Google Scholar
• von Ritter C, Grisham MB, Hollwarth M, Inauen W, Granger DN. Neutrophil-dcrived oxidants mediate formyl-methionyl-leucyl-phenylalanine-induced increases in mucosal permeability in rats. Gastroenterology 1989; 97: 778–80
   PubMed Web of Science ®Google Scholar
• Hollander D, Constance MV, Brettholz E, Petersen GM, Delahunty T, Rotter JL. Increased intestinal permeability in patients with Crohn's disease and their relatives. Ann Intern Med 1986; 105: 883–5
   PubMed Web of Science ®Google Scholar
• Zipser RD, Patterson JB, LeDuc LE. Chemotactic peptide stimulation of leukotrienes from healthy and inflamed rabbit colons. J Pharmacol Exp Ther 1987; 241: 218–22
   PubMed Web of Science ®Google Scholar
• Anderson RP, Woodhouse AF, Hobson CH, Myers DB, Broom MF, Chadwick VS. Hepatobiliary excretion and entero-hepatic circulation of bacterial chemotactic peptide (FMLP) in the rat. J Gastroenterol Hepatol 1987; 2: 45–62
   Web of Science ®Google Scholar
• Podolsky DK, Isselbacher KJ. Composition of human colonic mucin. Selective alteration in inflammatory bowel disease. J Clin Invest 1983; 72: 142–53
   PubMed Web of Science ®Google Scholar
• Madra JL, Barenberg D, Carlson S. Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J Cell Biol 1986; 102: 2125–36
   PubMed Web of Science ®Google Scholar
• Tamai H, Levin S, Gagniella TS. Free radical induced colitis in the rat: a new model of inflammatory bowel disease [abstract]. Gastroenterology 1990; 98: A476
   Google Scholar
• Mitchell DN, Rees RJW. Agents transmissable from Crohn's disease tissue. Lancet 1969; 2: 489–90
   PubMed Web of Science ®Google Scholar
• Sachar DB, Taub RN, Janowitz HD. A transmissable agents in Crohn's disease? New pursuit of an old concept. N Engl J Med 1975; 293: 354–5
   PubMed Web of Science ®Google Scholar
• Kirsner JB. Experimental ‘colitis' with particular reference to hypersensitivity reactions in the colon. Gastroenterology 1961; 40: 307–12
   PubMed Web of Science ®Google Scholar
• Goldgraber MB, Kirsner JB. The Arthus phenomenon in the colon of rabbits: a serial histologic study. Arch Pathol 1959; 67: 556–71
   Google Scholar
• Auer J. Local autoinoculation of the sensitized organism with foreign protein as a cause of abnormal reactions. J Exp Med 1920; 32: 427–44
   PubMedGoogle Scholar
• Kirsner JB, Elchlepp JG, Goldgraber ME, Ablaza J, Ford H. Production of an experimental ‘colitis' in rabbits. Arch Pathol 1959; 68: 392–408
   PubMedGoogle Scholar
• Kraft SC, Fitch FW, Kirsner JB. Histologic and immuno-histochemical features of ‘Auer' colitis in rabbits. Am J Pathol 1963; 43: 913–27
   PubMed Web of Science ®Google Scholar
• Hodgson HJF, Potter BJ, Skinner J, Jewell DP. Immune-complex mediated colitis in rabbits: an experimental model. Gut 1978; 19: 225–32
   PubMed Web of Science ®Google Scholar
• Mee AS, McLaughlin JE, Hodgson HJF, Jewell DP. Chronic immune colitis in rabbits. Gut 1979; 20: 1–5
   PubMed Web of Science ®Google Scholar
• Axelsson LG, Ahlstedt S. Characterization of immune-com-pled-induced chronic experimental colitis in rats with a therapeutic effect of sulphasalazine. Scand J Gastroenterol 1990; 25: 203–9
   PubMed Web of Science ®Google Scholar
• Perlman P, Hammarstrom S, Lagercrantz R, Campbell DES. Autoantibodies to colon in rats and human ulcerative colitis: cross reactivity with Escherichia coli 0:14 antigen. Proc Soc Exp Biol Med 1967; 125: 975–80
   PubMed Web of Science ®Google Scholar
• Rabin BS, Rogers SJ. A cell-mediated immune model of inflammatory bowel disease in the rabbit. Gastroenterology 1978; 75: 29–33
   PubMed Web of Science ®Google Scholar
• Glick ME, Falchuk ZM. Dinitrochlorobenzene-induced colitis in the guinea-pig: studies of colonic lamina propria lymphocytes. Gut 1981; 22: 120–5
   PubMed Web of Science ®Google Scholar
• Bicks RO, Azar MM, Rosenberg EW, Dunham WG, Luther J. Delayed hypersensitivity reactions in the intestinal tract. I. Studies of 2,4-dinitrochlorobenzene caused guinea pig and swine colon lesions. Gastroenterology 1967; 53: 422–36
   Web of Science ®Google Scholar
• Bicks RO, Brown G, Hicky D, Rosenberg EW. Further observations on a delayed hypersensitivity reaction in the guinea pig colon. Gastroenterology 1965; 48: 425–9
   PubMed Web of Science ®Google Scholar
• Kao AW, Zipser RD. Exaggerated prostaglandin production by colonic smooth muscle in rabbit colitis. Dig Dis Sci 1988; 33: 697–704
   PubMed Web of Science ®Google Scholar
• Morris GP, Beck PL, Herndge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced models of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795–803
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D, Simon PL, Schwartz LW, Griswold DE, Fondacaro JD, Wasserman MA. Inflammatory mediators of experimental colitis in rats. Gastroenterology 1989; 97: 326–37
   PubMed Web of Science ®Google Scholar
• Wallace JL, MacNaughton WK, Morris GP, Beck PL. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989; 96: 29–36
   PubMed Web of Science ®Google Scholar
• Vilaseca J, Salas A, Guarner F, Rodriguez R, Malagelada JR. Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis. Gastroenterology 1990; 98: 269–77
   PubMed Web of Science ®Google Scholar
• Peh K. H, Wan BYC, Parke DV. Determination of glutathione content and myeloperoxidase activity in rat models of induced rectocolonic inflammation. Br J Pharmacol 1989; 97: 548
   Google Scholar
• Allgayer H, Deschryver K, Stenson WF. Treatment with 16,16′-dimethyl-prostaglandin E2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation. Gastroenterology 1989; 96: 1290–1300
   PubMed Web of Science ®Google Scholar
• Teh HS, Phillips RA, Miller RG. Quantitative studies on the precursors of cytotoxic lymphocytes. The cellular basis of the cross-reactivity of TNP-specific clones. J Immunol 1978; 121: 1711–8
   PubMed Web of Science ®Google Scholar
• Kunin S, Gallily R. Recognition and lysis of altered self cells by macrophages, a modification of target cells by 2,4,6-tri-nitrobenzene sulfonic acid. Immunology 1983; 48: 265–72
   PubMed Web of Science ®Google Scholar
• Grisham MB, Volkmer C, Tso P, Yamada T. Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology 1991; 101: 540–7
   PubMed Web of Science ®Google Scholar
• Sharon P, Stenson WF. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984; 86: 453–60
   PubMed Web of Science ®Google Scholar
• Wallace JL, Keena CM. Leukotriene B4 potentiates colonic ulceration in the rat. Dig Dis Sci 1990; 35: 622–9
   PubMed Web of Science ®Google Scholar
• Wallace JL. Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis. Can J Physiol Pharmacol 1988; 66: 422–5
   PubMed Web of Science ®Google Scholar
• Barrett KE. Involvement of histamine in a rat model of inflammatory bowel disease [abstract]. Gastroenterology 1990; 98: A437
   PubMed Web of Science ®Google Scholar
• Morson BC. Pathology of ulcerative colitis. In: Inflammatory bowel disease. 2nd ed., JB Kirsner, RG Shorter. Lea & Febiger, Philadelphia 1980; 281–95
   Google Scholar